“Immunoassays are cost-effective and accurate tests that are standard to clinical diagnostics laboratories around the world. The testing format allows hundreds of blood samples to be analysed quickly as part of a panel of routine blood tests.”
“Currently, one in three people with diabetes develops CKD and PromarkerD is the only test available in the European Union for predicting the onset of the condition.“
Article: Proteomics strikes kidney disease test deal in Italy
